# Impella Versus Selective Biatrial Canulation for Left Ventricular Unloading During Extracorporeal Membrane Oxygenation

**Authors:** Mouhamed Djahoum Moussa, Jean Roux, Marie Jungling, Nassima Ramdane, Valentin Loobuyck, Benoit Brassart, Natacha Rousse, Céline Dupré, Agnès Mugnier, Abdelilah Khalipha, Adham Sameer A. Bardeesi, Oliver Lukowiak, Loïc Lefebvre, Francis Juthier, Emmanuel Robin, Julien Labreuche, Lise Thellier, André Vincentelli

PMC · DOI: 10.1155/cdr/3669575 · Cardiovascular Therapeutics · 2026-02-08

## TL;DR

The study compares two methods for unloading the left ventricle during ECMO support and finds that one method reduces bleeding and transfusions without affecting mortality.

## Contribution

This study provides a novel comparison of SBA-ECMO and ECPELLA for left ventricular unloading during VA-ECMO.

## Key findings

- SBA-ECMO was associated with fewer serious bleeding events compared to ECPELLA.
- SBA-ECMO resulted in less blood product consumption than ECPELLA.
- Both methods had similar ventilation-free days, thrombotic complications, and mortality rates.

## Abstract

Comparisons of preload unloading techniques for left ventricle overdistension during venoarterial (VA) extracorporeal membrane oxygenation (ECMO) support are scarce. We compared outcomes in patients with left ventricular distension treated with cannulated percutaneous atrioseptostomy combined with ECMO—specified as selective biatrial extracorporeal membrane oxygenation (SBA‐ECMO)—versus those treated with Impella CP/5.0 in combination with ECMO (ECPELLA).

Consecutive adult patients who received VA‐ECMO and underwent additional left ventricle unloading between January 2014 and March 2023 were studied. The primary endpoint was the number of ventilation‐free days. The secondary endpoints were serious bleeding, blood product consumption, thrombotic complications, and 28‐day mortality.

We included 57 patients, 27 of whom received SBA‐ECMO and 30 of whom received ECPELLA. The median number of ventilation‐free days was 10 days (0–23) with SBA‐ECMO and 5 days (0–23) with the ECPELLA (p = 0.61). According to the multivariable analyses, SBA‐ECMO was associated with a lower risk of serious bleeding (HR 0.31 [95% CI 0.12–0.80]) and less blood product consumption (RR 0.57 [95% CI 0.36–0.90]) than ECPELLA. Thrombotic complications and 28‐day mortality were similar between the groups before and after multivariable analyses.

In patients with left ventricle congestion during VA‐ECMO support, left ventricle unloading with SBA‐ECMO was associated with reduced serious bleeding and transfusions compared with ECPELLA, despite a similar number of ventilation‐free days, thrombotic complications, and mortality.

ClinicalTrials.gov identifiers: NCT03431467 and NCT05577195

## Full-text entities

- **Diseases:** left ventricular distension (MESH:D018487), Thrombotic complications (MESH:D013927), left ventricle (MESH:D020257), bleeding (MESH:D006470)
- **Chemicals:** ECPELLA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883551/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12883551/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883551/full.md

---
Source: https://tomesphere.com/paper/PMC12883551